Search
for
Sort by
Research 30 of 602
- Molecular characterization of xerosis cutis: A systematic review
- An Emollient PLUS Balm Is Useful for the Management of Xerosis in Patients Treated for Cancer: A Real-World, Prospective, Observational, Multicenter Study
- Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors
- Dermatologic Signs in Patients with Eating Disorders
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- A current review of the cutaneous manifestations of renal disease
- Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis
- Prevalence and associated factors of skin diseases in aged nursing home residents: a multicentre prevalence study
- 9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma
- Care of the newborn with ichthyosis
- Skin signs in anorexia nervosa
- Dermatological side effects of epidermal growth factor receptor inhibitors: ′Pride′ complex
- Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID ‐19 pandemic
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Cutaneous side-effects of EGFR inhibitors and their management.
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses
- The skin landscape in diabetes mellitus. Focus on dermocosmetic management
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Non-Rash Skin Toxicities Associated with Novel Targeted Therapies
- Skin Disease Among Latino Farmworkers in North Carolina
- Changes in dermatological complaints among healthcare professionals during the COVID-19 outbreak in Turkey
- Skin disorders in elderly subjects
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Menopause, skin and common dermatoses. Part 2: skin disorders
- Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia